Skip to content

The bacteria Fusobacterium nucleatum is prevalent in periodontal disease (gum disease), but also in some chronic diseases and cancers, such as colorectal cancer. The bacteria F. nucleatum is normally found in the mouth (oral) microbiome, and its numbers increase as periodontal disease inflammation increases.

It is thought that sometimes the bacteria leaves the mouth and travels to other parts of the body, where it can promote cancer and other diseases.

A recent study found that the antibiotic FP 100 (Hygromycin A) totally eliminates the F. nucleatum bacteria in the mouth, and without causing harm to the mouth microbiome or gut microbiome. This is because it is a narrow spectrum antibiotic - only targets the harmful bacteria, and not all (both good and harmful) bacteria. While the study was only done in mice, this is promising and welcome news.

Eliminating the harmful bacteria in the mouth would potentially prevent some chronic diseases and cancers. Now we need further studies to see if this finding holds up in humans.

From Medical Xpress: First narrow-spectrum antibiotic successfully eliminates  Fusobacterium nucleatum, a gum disease pathogen

In a study published in the Journal of Oral Microbiology, ADA Forsyth scientists found that FP 100 (Hygromycin A), a first-in-class, small molecule, narrow-spectrum antibiotic, successfully eradicates Fusobacterium nucleatum without harming the oral or gut microbiomes. ...continue reading "A Promising Antibiotic For Gum Disease"

Credit: Wikipedia

Cancer tumors have a different microbiome (community of microbes) than healthy tissue. Researchers have been finding the bacteria Fusobacterium nucleatum (F. nucleatum) in a number of cancers, with high levels of its presence associated with a poorer outcome for the person (more metastases and death).

A recent study found that one strain or subtype of  F. nucleatum (called Fna C2)  is found in tumors of about 50% of aggressive colon cancers.

Interestingly, F. nucleatum is a normal oral bacteria - one found in the mouth of people, and also associated with periodontal disease. It is rarely found in the gastrointestinal (GI) tract of healthy persons.

It is thought that the bacteria somehow travels from the mouth to the stomach, where it can withstand stomach acid, and then grows there in the gastrointestinal tract. F. nucleatum is cancer promoting - for example, it has a supporting role in tumor progression. It appears to be resistant to cancer treatments.

Researchers are now wondering if certain beneficial or good bacteria ingested by the person or somehow delivered to the tumor site  can battle the F. nucleatum, perhaps as part of cancer therapy. Stay tuned....

From Science Daily: Bacteria subtype linked to growth in up to 50% of human colorectal cancers

Researchers at Fred Hutchinson Cancer Center have found that a specific subtype of a microbe commonly found in the mouth is able to travel to the gut and grow within colorectal cancer tumors. This microbe is also a culprit for driving cancer progression and leads to poorer patient outcomes after cancer treatment. ...continue reading "A Specific Bacteria and Colorectal Cancer"

Pancreas with cancer (red dot) Credit: Wikipedia

Pancreatic cancer is typically discovered only when it is advanced, very hard to treat, and typically with poor outcomes. Interesting recent research found that the gut microbiome is distinctive in persons with pancreatic cancer, even in the early stages. Perhaps this finding will lead to an easy noninvasive way to screen for pancreatic cancer.

Researchers in Spain and Germany looked at both the community of microbes (microbiome) living in the mouth and the gut (shown in a person's feces). They took samples from healthy persons, individuals with pancreatic cancer, and persons with chronic pancreatitis  and found that the bacteria in the stool were predictive for pancreatic cancer (but not those in the mouth).

The "fecal microbiota signature" or pattern of microbes in those with pancreatic cancer had an increase in some microbes (e.g., Fusobacterium nucleatum) and a decrease in others (e.g., Faecalibacterium prausnitzii) - when compared to healthy individuals.

By the way, Fusobacterium nucleatum is found increased in other cancers, such as colon cancer, and beneficial and anti-inflammatory Faecalibacterium prausnitzii is reduced in a number of diseases. Eating a diet rich in high fiber foods (whole grains, fruits, vegetables, legumes, seeds, nuts) increase the numbers of F. prausnitzi in a person's gut microbial community.

From Medical Xpress: Distinct gut microbial profile may identify pancreatic cancer, irrespective of stage

A specific panel of gut microbes may identify pancreatic cancer, irrespective of how far the disease has progressed, suggests research published online in the journal Gut. ...continue reading "Pancreatic Cancer Has a Distinct Gut Microbial Pattern"